Clinical Trials Logo

Precancerous Condition clinical trials

View clinical trials related to Precancerous Condition.

Filter by:

NCT ID: NCT00550589 Completed - Anal Cancer Clinical Trials

Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus

Start date: September 2007
Phase: Phase 2
Study type: Interventional

RATIONALE: High-grade squamous intraepithelial lesions of the skin near the anus are caused by the human papillomavirus (HPV). Antiviral drugs,, such as cidofovir, act against viruses and may stop these lesions from becoming cancer. PURPOSE: This phase II trial is studying the side effects and how well topical cidofovir works in treating HIV-infected patients with high-grade squamous intraepithelial lesions of the skin near the anus.

NCT ID: NCT00524017 Completed - Clinical trials for Head and Neck Cancer

Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract

Start date: May 2007
Phase: Phase 2
Study type: Interventional

RATIONALE: Monoclonal antibodies, such as cetuximab, can block abnormal cell growth in different ways. Some block the ability of abnormal cells to grow and spread. Others find abnormal cells and help kill them or carry cell-killing substances to them. PURPOSE: This randomized phase II trial is studying how well cetuximab works in treating patients with precancerous lesions of the upper aerodigestive tract.

NCT ID: NCT00522197 Completed - Lung Cancer Clinical Trials

ACAPHA in Preventing Lung Cancer in Former Smokers With Bronchial Intraepithelial Neoplasia

Start date: September 2002
Phase: Phase 2
Study type: Interventional

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. The use of ACAPHA, a combination of six herbs, may prevent lung cancer from forming in former smokers with bronchial intraepithelial neoplasia. PURPOSE: This randomized phase II trial is studying the side effects and how well ACAPHA works in preventing lung cancer in former smokers with bronchial intraepithelial neoplasia.

NCT ID: NCT00516347 Recruiting - Esophageal Cancer Clinical Trials

Studying Genes for Barrett's Esophagus in Brothers and Sisters

Start date: June 2002
Phase: N/A
Study type: Observational

RATIONALE: Learning about how often heartburn and other risk factors occur in brothers and sisters and other family members of patients with Barrett's esophagus may help identify other individuals at risk and identify genes for Barrett's esophagus. PURPOSE: This clinical trial is studying genes for Barrett's esophagus in brothers and sisters.

NCT ID: NCT00513526 Completed - Infection Clinical Trials

Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection

Start date: November 2007
Phase: Phase 2
Study type: Interventional

RATIONALE: Vaccines made from human papillomavirus may help the body build an effective immune response to kill HIV cells. PURPOSE: This phase II trial is studying the side effects and how well human papillomavirus vaccine therapy works in treating men with HIV-1 infection.

NCT ID: NCT00512746 Completed - Lung Cancer Clinical Trials

Screening for Lung Cancer in Current or Past Smokers With Chronic Obstructive Pulmonary Disease

Start date: August 2007
Phase: N/A
Study type: Interventional

RATIONALE: Screening tests or exams may help doctors find lung cancer sooner, when it may be easier to treat. PURPOSE: This randomized clinical trial is studying screening tests or exams to see how well they work compared to usual care in finding early stage lung cancer in current or past smokers with chronic obstructive pulmonary disease.

NCT ID: NCT00489671 Completed - Pancreatic Cancer Clinical Trials

Urine Cadmium Levels in Predicting Pancreatic Cancer Risk in Patients With Chronic Pancreatitis

Start date: June 2003
Phase: N/A
Study type: Observational

RATIONALE: Measuring cadmium levels in urine samples from patients with chronic pancreatitis may help doctors predict which patients may develop pancreatic cancer. It may also help the study of cancer in the future. PURPOSE: This clinical trial is studying urine cadmium levels in predicting pancreatic cancer risk in patients with chronic pancreatitis.

NCT ID: NCT00477880 Completed - Gastric Cancer Clinical Trials

Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer

Start date: April 2001
Phase: Phase 1
Study type: Interventional

RATIONALE: Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. PURPOSE: This clinical trial is studying how well cetuximab works in treating patients with Ménétrier disease at high risk of developing stomach cancer.

NCT ID: NCT00468910 Active, not recruiting - Rectal Cancer Clinical Trials

Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer

Start date: March 2007
Phase: Phase 2
Study type: Interventional

This randomized phase II trial is studying how well aspirin works in preventing colorectal cancer in patients at increased risk of colorectal cancer. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of aspirin may prevent colorectal cancer.

NCT ID: NCT00462813 Completed - Cervical Cancer Clinical Trials

Diindolylmethane in Treating Patients With Abnormal Cervical Cells

Start date: October 2004
Phase: Phase 3
Study type: Interventional

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. The use of diindolylmethane, a substance found in cruciferous vegetables, may keep cervical intraepithelial neoplasia or cervical cancer from forming. PURPOSE: This randomized phase III trial is studying diindolylmethane to see how well it works compared to a placebo in treating patients with abnormal cervical cells.